• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉贝洛尔在动物和人体内的代谢。

Metabolism of labetalol by animals and man.

作者信息

Martin L E, Hopkins R, Bland R

出版信息

Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.

PMID:990152
Abstract

1 The disposition and metabolism of labetalol and either 14C- or 3H-labetalol has been studied in mouse, rat, rabbit, dog and man. 2 Radiolabelled labetalol was administered orally at doses of 100 mg/kg to the mouse, up to 50 mg/kg to the rat and rabbit, 20 mg/kg to the dog and 200 mg to man. From measurements of the total plasma radioactivity it was shown that labetalol was well absorbed by all the species. When the measurements of plasma radioactivity and labetalol concentrations were compared, it was found labetaol had been extensively metabolized by the first-pass effect in rat, rabbit and man. Metabolism by this route occurred to a lesser extent in the dog. 3 Radiochemical analysis of the tissues from rats, rabbits and dogs showed that the highest concentrations of radioactivity were found in the lung, liver and kidney. Very little radioactivity was present in the brain. Over 99% of the radioactivity was cleared from the tissues by 7 d. When doses of up to 200 mg 14C-labetalol/kg were given to pregnant rats and 50 mg 14C-labetalol/kg to pregnant rabbits, autoradiographic and radiochemical analysis of the full-term foetuses showed that only small amounts of radioactivity were present in the foetus. 4 The mouse excreted 72%, the rate 48%, the rabbit 61%, the dog 66% and man 60% of the oral dose of radioactivity in the urine. Analysis of themouse and rat faeces showed that the remainder of the dose of radioactivity was excreted in the faeces. 5 Radiochemical analysis of the urine and faeces collected from rats and dogs after an intravenous dose of 1 mg 14C- and 3H-labetalol/kg showed that excretion of radioactivity occurred via both the kidney and bile. 6 An intravenous dose of 1 mg 3H-labetalol/kg to dog and 1 mg 'cold' labetalol/kg to man was not as extensively metabolized as a similar oral dose. 7 The percentage of the dose excreted in the urine as unchanged drug was 2% in the rabbit, 11% in the rat, 19% in the dog and up to 5% in man. The O-phenyl glucuronide was the major metabolite present in the mouse, rat, and rabbit urine. Dog and man also formed this metabolite, but to a lesser extent. A second glucuronide was the major metabolite present in dog urine. This was probably formed through conjugation of glucuronic acid was the secondary alcohol group of labetalol. The major metabolite present in human urine was an unidentified conjugate of labetalol. Minor metabolites of labetalol present in rat, rabbit and dog urine were hydroxylabetalol and its glucuronyl conjugate.

摘要
  1. 已在小鼠、大鼠、兔子、狗和人体中研究了拉贝洛尔以及14C - 或3H - 拉贝洛尔的处置和代谢情况。2. 给小鼠口服放射性标记的拉贝洛尔,剂量为100mg/kg;给大鼠和兔子口服的剂量最高可达50mg/kg;给狗口服的剂量为20mg/kg;给人体口服的剂量为200mg。通过测量血浆总放射性表明,所有物种对拉贝洛尔的吸收都很好。当比较血浆放射性测量值和拉贝洛尔浓度时,发现拉贝洛尔在大鼠、兔子和人体中因首过效应而被广泛代谢。这种途径的代谢在狗中发生的程度较小。3. 对大鼠、兔子和狗的组织进行放射化学分析表明,在肺、肝和肾中发现的放射性浓度最高。脑中的放射性很少。超过99%的放射性在7天内从组织中清除。给怀孕大鼠给予高达200mg 14C - 拉贝洛尔/kg的剂量,给怀孕兔子给予50mg 14C - 拉贝洛尔/kg的剂量,对足月胎儿进行放射自显影和放射化学分析表明,胎儿中仅存在少量放射性。4. 小鼠经尿液排泄了口服剂量放射性的72%,大鼠为48%,兔子为61%,狗为66%,人体为60%。对小鼠和大鼠粪便的分析表明,放射性剂量的其余部分通过粪便排泄。5. 对静脉注射1mg 14C - 和3H - 拉贝洛尔/kg后从大鼠和狗收集的尿液和粪便进行放射化学分析表明,放射性通过肾脏和胆汁排泄。6. 给狗静脉注射1mg 3H - 拉贝洛尔/kg和给人体静脉注射1mg“非放射性”拉贝洛尔/kg时,其代谢程度不如类似口服剂量广泛。7. 以未变化药物形式经尿液排泄的剂量百分比在兔子中为2%,在大鼠中为11%,在狗中为19%,在人体中高达5%。O - 苯基葡萄糖醛酸苷是小鼠、大鼠和兔子尿液中存在的主要代谢物。狗和人体也形成这种代谢物,但程度较小。第二种葡萄糖醛酸苷是狗尿液中存在的主要代谢物。这可能是通过葡萄糖醛酸与拉贝洛尔的仲醇基团结合形成的。人体尿液中存在的主要代谢物是一种未鉴定的拉贝洛尔共轭物。大鼠、兔子和狗尿液中存在的拉贝洛尔次要代谢物是羟基拉贝洛尔及其葡萄糖醛酸共轭物。

相似文献

1
Metabolism of labetalol by animals and man.拉贝洛尔在动物和人体内的代谢。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.
2
Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.酮色林在大鼠、兔和犬体内的药代动力学及组织分布
Arzneimittelforschung. 1988 Jun;38(6):775-84.
3
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.抗蠕虫药甲基-14C-5-环丙基羰基-2-苯并咪唑氨基甲酸酯(环苯达唑)对大鼠和犬给药后的放射性分布情况。
Arzneimittelforschung. 1977;27(3):593-8.
4
Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.新型血栓素A2受体拮抗剂雷马曲班在动物体内的药代动力学与代谢。第二篇通讯:在雄性、雌性及妊娠大鼠体内的器官和组织分布以及血浆蛋白结合特性
Arzneimittelforschung. 1997 Aug;47(8):939-48.
5
Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing.静脉注射和口服给药后,大鼠、犬和人体中14C-格拉司琼的代谢与处置
Xenobiotica. 1994 Nov;24(11):1119-31. doi: 10.3109/00498259409038671.
6
HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.高效液相色谱-核磁共振联用技术用于严重柱超载情况:快速鉴定经[14C]-ZD6126处理的大鼠和犬尿液及胆汁样本中的代谢产物
J Pharm Biomed Anal. 2007 Feb 19;43(3):1065-77. doi: 10.1016/j.jpba.2006.09.010. Epub 2006 Oct 9.
7
Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.一种新型抗心律失常药物α,α-二甲基-4-(α,α,β,β-四氟苯乙基)苄胺在大鼠、狗、猴、狒狒和人体内的生理处置及代谢命运。
Drug Metab Dispos. 1976 Jul-Aug;4(4):387-401.
8
Affinity of labetalol for ocular melanin.拉贝洛尔对眼黑色素的亲和力。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):711-20.
9
Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.新型类视黄醇4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯甲酸的代谢与处置研究。第四次通讯:在各种动物和人类中的吸收、代谢、排泄及血浆蛋白结合情况
Arzneimittelforschung. 1997 Mar;47(3):259-69.
10
Physiological disposition and metabolism of 2-aminomethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride.盐酸2-氨甲基-4-(1,1-二甲基乙基)-6-碘苯酚的生理处置与代谢
Drug Metab Dispos. 1979 Sep-Oct;7(5):330-4.

引用本文的文献

1
Enantioselective transplacental transfer of xenobiotics: mechanisms, plasma protein binding, and health implications for fetal development.外源性物质的对映体选择性经胎盘转运:机制、血浆蛋白结合以及对胎儿发育的健康影响
Arch Toxicol. 2025 Jun 7. doi: 10.1007/s00204-025-04108-x.
2
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.体外治疗β-肾上腺素能拮抗剂中毒:EXTRIP 工作组的系统评价和建议。
Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.
3
Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes.
妊娠相关激素增加人肝细胞中UGT1A1介导的拉贝洛尔代谢。
Front Pharmacol. 2021 Apr 15;12:655320. doi: 10.3389/fphar.2021.655320. eCollection 2021.
4
Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy.孕周和体重对拉贝洛尔孕期药代动力学的影响。
Clin Pharmacokinet. 2014 Apr;53(4):373-83. doi: 10.1007/s40262-013-0123-0.
5
Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.美托洛尔和拉贝洛尔在大鼠、小鼠和 Caco-2 细胞中的渗透性比较:作为 BCS 分类的参考标准。
Mol Pharm. 2013 Mar 4;10(3):958-66. doi: 10.1021/mp300410n. Epub 2013 Feb 4.
6
CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects.CYP2C19 基因型对健康中国男性受试者拉贝洛尔的药代动力学有重要影响。
Eur J Clin Pharmacol. 2013 Apr;69(4):799-806. doi: 10.1007/s00228-012-1428-x. Epub 2012 Oct 23.
7
Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination.孕酮对尿苷二磷酸葡萄糖醛酸基转移酶(UGT)1A1的调节及其对拉贝洛尔消除的影响。
Xenobiotica. 2008 Jan;38(1):62-75. doi: 10.1080/00498250701744633.
8
Direct vasodilatation by labetalol in anaesthetized dogs.拉贝洛尔对麻醉犬的直接血管舒张作用。
Br J Pharmacol. 1980 Oct;70(2):287-93. doi: 10.1111/j.1476-5381.1980.tb07934.x.
9
Effect of food on the bioavailability of labetalol.食物对拉贝洛尔生物利用度的影响。
Br J Clin Pharmacol. 1980 Apr;9(4):435-7. doi: 10.1111/j.1365-2125.1980.tb01076.x.
10
The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.食物对高清除率药物口服及静脉药代动力学的影响:拉贝洛尔的研究
Br J Clin Pharmacol. 1982 Jul;14(1):73-8. doi: 10.1111/j.1365-2125.1982.tb04936.x.